Skip to content

Hydroxychloroquine

Plaquenil (hydroxychloroquine) is a small molecule pharmaceutical. Hydroxychloroquine was first approved as Plaquenil on 1982-01-01. It is used to treat malaria, photosensitivity disorders, porphyria cutanea tarda, rheumatic diseases, and rheumatoid arthritis amongst others in the USA. It is known to target toll-like receptor 9 and toll-like receptor 7.
Trade Name Plaquenil
Common Name Hydroxychloroquine
ChEMBL ID CHEMBL1535
Indication malaria, photosensitivity disorders, porphyria cutanea tarda, rheumatic diseases, rheumatoid arthritis, systemic lupus erythematosus
Drug Class
Hydroxychloroquine
Get full access now